Drug Shortage Report for TRANEXAMIC ACID INJECTION
| Report ID | 260726 |
| Drug Identification Number | 02531208 |
| Brand name | TRANEXAMIC ACID INJECTION |
| Common or Proper name | TRANEXAMIC ACID INJECTION Vials |
| Company Name | EUGIA PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | TRANEXAMIC ACID |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 |
| ATC code | B02AA |
| ATC description | ANTIFIBRINOLYTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2025-06-20 |
| Estimated end date | 2025-12-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-07-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-07-10 | French | Compare |
| v4 | 2025-07-10 | English | Compare |
| v3 | 2025-06-21 | English | Compare |
| v2 | 2025-06-20 | French | Compare |
| v1 | 2025-06-20 | English | Compare |
Showing 1 to 5 of 5